BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 209 filers reported holding BRIDGEBIO PHARMA INC in Q2 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,307,648 | +13.3% | 201,276 | -26.1% | 0.00% | +50.0% |
Q2 2023 | $4,683,165 | -27.2% | 272,277 | -29.8% | 0.00% | -50.0% |
Q1 2023 | $6,434,465 | +195.1% | 388,086 | +35.6% | 0.00% | +300.0% |
Q4 2022 | $2,180,448 | +15.4% | 286,148 | +50.6% | 0.00% | 0.0% |
Q3 2022 | $1,889,000 | +93.0% | 190,034 | +76.1% | 0.00% | 0.0% |
Q2 2022 | $979,000 | +47.9% | 107,895 | +65.6% | 0.00% | – |
Q1 2022 | $662,000 | -43.0% | 65,166 | -6.4% | 0.00% | -100.0% |
Q4 2021 | $1,161,000 | -70.6% | 69,589 | -17.5% | 0.00% | -50.0% |
Q3 2021 | $3,951,000 | -80.2% | 84,311 | -74.2% | 0.00% | -80.0% |
Q2 2021 | $19,938,000 | -38.6% | 327,062 | -37.9% | 0.01% | -41.2% |
Q1 2021 | $32,448,000 | +739.3% | 526,760 | +868.8% | 0.02% | +750.0% |
Q4 2020 | $3,866,000 | +158.9% | 54,370 | +36.7% | 0.00% | +100.0% |
Q3 2020 | $1,493,000 | +9.1% | 39,785 | -5.2% | 0.00% | 0.0% |
Q2 2020 | $1,368,000 | +81.2% | 41,956 | +61.0% | 0.00% | 0.0% |
Q1 2020 | $755,000 | +166.8% | 26,053 | +221.6% | 0.00% | – |
Q4 2019 | $283,000 | +105.1% | 8,101 | +24.1% | 0.00% | – |
Q3 2019 | $138,000 | – | 6,527 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 6,068,125 | $160,016,456 | 65.94% |
Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $819,077,805 | 28.79% |
Cormorant Asset Management, LP | 4,662,530 | $122,950,916 | 7.17% |
Frazier Life Sciences Management, L.P. | 2,725,949 | $71,883,275 | 4.77% |
Octagon Capital Advisors LP | 971,639 | $25,622,120 | 3.94% |
M28 Capital Management LP | 121,200 | $3,196,044 | 3.66% |
VIKING GLOBAL INVESTORS LP | 25,120,991 | $662,440,533 | 2.69% |
BOONE CAPITAL MANAGEMENT LLC | 313,381 | $8,263,857 | 2.61% |
Fernwood Investment Management, LLC | 235,620 | $6,213,299 | 2.23% |
SOUTHPORT MANAGEMENT, L.L.C. | 15,000 | $395,550 | 2.15% |